Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study.
Saved in:
| Title: | Sequential chemotherapy regimen of induction with panitumumab and paclitaxel followed by radiotherapy and panitumumab in patients with locally advanced head and neck cancer unfit for platinum derivatives. The phase II, PANTERA/TTCC-2010-06 study. |
|---|---|
| Authors: | Martínez-Trufero J; Medical Oncology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain. jmtrufero@seom.org., Lozano Borbalas A; Radiation Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain., Pajares Bernad I; Medical Oncology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain., Taberna Sanz M; Medical Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain., Ortega Izquierdo E; Medical Oncology Department, University Hospital Miguel Servet, Av. Isabel la Católica 1-3, 50009, Zaragoza, Spain., Cirauqui Cirauqui B; Medical Oncology Service, Institut Català D'Oncologia (ICO) Badalona, Barcelona, Spain., Rubió-Casadevall J; Medical Oncology Service, Institut Català D'Oncologia (ICO) Girona, University Hospital Josep Trueta, Girona, Spain., Plana Serrahima M; Medical Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain., Ponce Ortega JM; Radiation Oncology Service, University Hospital Miguel Servet, Zaragoza, Spain., Planas Toledano I; Radiation Oncology Service, Institut Català D'Oncologia (ICO) Badalona, Barcelona, Spain., Caballero J; Medical Oncology Service, University and Polytechnic Hospital La Fe, Valencia, Spain., Marruecos Querol J; Radiation Oncology Service, Institut Català D'Oncologia (ICO) Girona, University Hospital Josep Trueta, Girona, Spain., Iglesias Docampo L; Medical Oncology Service, University Hospital 12 de Octubre, Madrid, Spain., Lambea Sorrosal J; Medical Oncology Service, University Hospital Lozano Blesa, Zaragoza, Spain., Adansa JC; Biomedical Research Institute of Salamanca, Salamanca, Spain., Mesía Nin R; Medical Oncology Service, Institut Català D'Oncologia (ICO) Hospitalet, Barcelona, Spain. |
| Corporate Authors: | Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (TTCC) |
| Source: | Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Aug; Vol. 23 (8), pp. 1666-1677. Date of Electronic Publication: 2021 Apr 19. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1699-3055 |
|---|---|
| DOI: | 10.1007/s12094-021-02567-z |
